Mid- and Long-Term Outcome of Currently Available Endografts for the Treatment of Infrarenal Abdominal Aortic Aneurysm.

Mid- and Long-Term Outcome of Currently Available Endografts for the Treatment of Infrarenal Abdominal Aortic Aneurysm. Surg Technol Int. 2018 Aug 14;33: Authors: Jonker LT, de Niet A, Reijnen MMPJ, Tielliu IFJ, Zeebregts CJ Abstract Currently, there is a wide range of commercially available endografts for infrarenal abdominal aortic aneurysm (AAA) repair. Results of long-term follow up after endovascular aneurysm repair (EVAR) are limited. Thereby, the durability of these endografts and the difference between manufacturers is not fully clear. In this review, studies with mid- and long-term results, with a minimum median follow up of 36 months per endograft, were included describing results with Cook Zenith� Flex� endograft (Cook Medical Inc., Bloomington, Indiana) (n=6), Cordis Corporate INCRAFT� (Cordis Corporation, Freemont, California) (n=1), Gore� EXCLUDER� (W.L. Gore & Associates Inc., Flagstaff, Arizona) (n=3), Medtronic Endurant� (Medtronic plc, Santa Rosa, California) (n= 6), and Vascutek Anaconda� (Vascutek Ltd., Inchinnan, Scotland) (n=2). The assisted technical success varied between 83% and 100%, and the perioperative mortality, early reintervention, and early conversion rates were comparable for the studied endografts. At three-year follow up, the freedom from AAA-rupture and AAA-related death varied between 98% and 100%. The results demonstrated an increasing complication and reintervention rate over ...
Source: Surgical Technology International - Category: Surgery Tags: Surg Technol Int Source Type: research